Boston Children's Hospital

St. Jude Children's Research Hospital, Inc. operates as a non-profit health care organization. The Hospital offers child care, cancer predisposition, orthopaedic surgery, infectious diseases, behavioural health, cardiovascular medicine, bone marrow transplant, blood disorders, and skilled nursing services.In January 2022, Imaging Biometrics LLC has signed a data use agreement with St Jude Children's Research Hospital.In July 2008, Amsterdam Molecular Therapeutics (AMT) and St Jude Children's Research Hospital agreed to develop a gene therapy for hemophilia B. Under the terms of the agreement, AMT would receive exclusive commercial rights to the therapy.In May 2005, ChemBridge Research Laboratories and St Jude's extended their multiyear cancer collaboration. They were using ChemBridge's discovery medicinal chemistry platform with St Jude's anaplastic lymphoma kinase targets.In January 2010, St Jude reported preclinical data showing that statins prolonged the lives of mice with s

St. Jude Children's Research Hospital, Inc. operates as a non-profit health care organization. The Hospital offers child care, cancer predisposition, orthopaedic surgery, infectious diseases, behavioural health, cardiovascular medicine, bone marrow transplant, blood disorders, and skilled nursing services.In January 2022, Imaging Biometrics LLC has signed a data use agreement with St Jude Children's Research Hospital.In July 2008, Amsterdam Molecular Therapeutics (AMT) and St Jude Children's Research Hospital agreed to develop a gene therapy for hemophilia B. Under the terms of the agreement, AMT would receive exclusive commercial rights to the therapy.In May 2005, ChemBridge Research Laboratories and St Jude's extended their multiyear cancer collaboration. They were using ChemBridge's discovery medicinal chemistry platform with St Jude's anaplastic lymphoma kinase targets.In January 2010, St Jude reported preclinical data showing that statins prolonged the lives of mice with s

The Children's Hospital Boston, based in Boston, MA, is specialized in pediatric care and has a large pediatric research facility focused on the R&D of therapeutics for debilitating childhood diseases. Its main research areas include anesthesiology, cardiology, genetics, hematology, immunology, infectious diseases, mental retardation, neonatology, neurology, oncology, orthopedics, otolaryngology, pathology, pulmonary medicine, surgery, radiology, and urology.In June 2021, Boston Children’s Hospital and ElevateBio announced that they have entered into a five-year collaborative agreement.In May 2018, MolMed signed a five years master service agreement, and a related first project agreement, with Boston Children's Hospital for the production of lentiviral vectors used for in rare diseases